These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 29652114)
1. Associations between vitamin D levels and polycystic ovary syndrome phenotypes. Davis EM; Peck JD; Hansen KR; Neas BR; Craig LB Minerva Endocrinol; 2019 Jun; 44(2):176-184. PubMed ID: 29652114 [TBL] [Abstract][Full Text] [Related]
2. Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome. Li HW; Brereton RE; Anderson RA; Wallace AM; Ho CK Metabolism; 2011 Oct; 60(10):1475-81. PubMed ID: 21550088 [TBL] [Abstract][Full Text] [Related]
3. Vitamin D Deficiency among Adolescent Females with Polycystic Ovary Syndrome. Sadhir M; Kansra AR; Menon S J Pediatr Adolesc Gynecol; 2015 Oct; 28(5):378-81. PubMed ID: 26209866 [TBL] [Abstract][Full Text] [Related]
4. Effects of vitamin D supplementation on insulin sensitivity and androgen levels in vitamin-D-deficient polycystic ovary syndrome patients. Karadağ C; Yoldemir T; Yavuz DG J Obstet Gynaecol Res; 2018 Feb; 44(2):270-277. PubMed ID: 29094433 [TBL] [Abstract][Full Text] [Related]
5. Impact of hypovitaminosis D on clinical, hormonal and insulin sensitivity parameters in normal body mass index polycystic ovary syndrome women. Ganie MA; Marwaha RK; Nisar S; Farooqi KJ; Jan RA; Wani SA; Gojwari T; Shah ZA J Obstet Gynaecol; 2016 May; 36(4):508-12. PubMed ID: 26772667 [TBL] [Abstract][Full Text] [Related]
6. Low vitamin D3 and high anti-Müllerian hormone serum levels in the polycystic ovary syndrome (PCOS): Is there a link? Cappy H; Giacobini P; Pigny P; Bruyneel A; Leroy-Billiard M; Dewailly D; Catteau-Jonard S Ann Endocrinol (Paris); 2016 Oct; 77(5):593-599. PubMed ID: 26997468 [TBL] [Abstract][Full Text] [Related]
7. Vitamin D in the aetiology and management of polycystic ovary syndrome. Thomson RL; Spedding S; Buckley JD Clin Endocrinol (Oxf); 2012 Sep; 77(3):343-50. PubMed ID: 22574874 [TBL] [Abstract][Full Text] [Related]
8. Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria. Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T Arch Gynecol Obstet; 2016 Feb; 293(2):447-56. PubMed ID: 26408006 [TBL] [Abstract][Full Text] [Related]
9. Apa-I polymorphism in VDR gene is related to metabolic syndrome in polycystic ovary syndrome: a cross-sectional study. Santos BR; Lecke SB; Spritzer PM Reprod Biol Endocrinol; 2018 Apr; 16(1):38. PubMed ID: 29669566 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities. Figurová J; Dravecká I; Javorský M; Petríková J; Lazúrová I Wien Klin Wochenschr; 2016 Sep; 128(17-18):641-8. PubMed ID: 25787215 [TBL] [Abstract][Full Text] [Related]
11. Vitamin D deficiency effects on cardiovascular parameters in women with polycystic ovary syndrome: A retrospective, cross-sectional study. Butler AE; Dargham SR; Abouseif A; El Shewehy A; Atkin SL J Steroid Biochem Mol Biol; 2021 Jul; 211():105892. PubMed ID: 33785436 [TBL] [Abstract][Full Text] [Related]
12. [The role of vitamin D deficiency in the etiology of polycystic ovary syndrome disorders]. Brzozowska M; Karowicz-Bilińska A Ginekol Pol; 2013 Jun; 84(6):456-60. PubMed ID: 24032264 [TBL] [Abstract][Full Text] [Related]
13. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance. Naderpoor N; Shorakae S; Abell SK; Mousa A; Joham AE; Moran LJ; Stepto NK; Spritzer PM; Teede HJ; de Courten B J Steroid Biochem Mol Biol; 2018 Mar; 177():209-215. PubMed ID: 28734987 [TBL] [Abstract][Full Text] [Related]
14. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Wehr E; Pilz S; Schweighofer N; Giuliani A; Kopera D; Pieber TR; Obermayer-Pietsch B Eur J Endocrinol; 2009 Oct; 161(4):575-82. PubMed ID: 19628650 [TBL] [Abstract][Full Text] [Related]
15. Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome. Panidis D; Balaris C; Farmakiotis D; Rousso D; Kourtis A; Balaris V; Katsikis I; Zournatzi V; Diamanti-Kandarakis E Clin Chem; 2005 Sep; 51(9):1691-7. PubMed ID: 16037412 [TBL] [Abstract][Full Text] [Related]
16. Vitamin D levels and lipid profiles in patients with polycystic ovary syndrome. Moieni A; Haghollahi F; Dashtkoohi M; Abiri A; Salari E; Najafi MS; Tajik N BMC Womens Health; 2024 Aug; 24(1):472. PubMed ID: 39192256 [TBL] [Abstract][Full Text] [Related]
17. Is there any association between vitamin D levels and polycystic ovary syndrome (PCOS) phenotypes? Eftekhar M; Mirhashemi ES; Molaei B; Pourmasumi S Arch Endocrinol Metab; 2020 Feb; 64(1):11-16. PubMed ID: 31576965 [TBL] [Abstract][Full Text] [Related]
18. Genetic variant in vitamin D-binding protein is associated with metabolic syndrome and lower 25-hydroxyvitamin D levels in polycystic ovary syndrome: A cross-sectional study. Santos BR; Lecke SB; Spritzer PM PLoS One; 2017; 12(3):e0173695. PubMed ID: 28278285 [TBL] [Abstract][Full Text] [Related]
19. Classic PCOS phenotype is not associated with deficiency of endogenous vitamin D and VDR gene polymorphisms rs731236 (TaqI), rs7975232 (ApaI), rs1544410 (BsmI), rs10735810 (FokI): a case-control study of lower Silesian women. Jedrzejuk D; Łaczmański Ł; Milewicz A; Kuliczkowska-Płaksej J; Lenarcik-Kabza A; Hirnle L; Zaleska-Dorobisz U; Lwow F Gynecol Endocrinol; 2015; 31(12):976-9. PubMed ID: 26422783 [TBL] [Abstract][Full Text] [Related]
20. Comparison of 25-hydroxyvitamin D and metabolic parameters between women with and without polycystic ovarian syndrome. Ng BK; Lee CL; Lim PS; Othman H; Ismail NAM Horm Mol Biol Clin Investig; 2017 Jun; 31(3):. PubMed ID: 28586302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]